Company / Debt per Share
MADRIGAL PHARMACEUTICALS, INC. Debt per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$15.45
FY2025
5-year range
$0.00 / $15.45
FY2021-FY2025
Trend
+161.1%
vs FY2024
Sector context
#18 of 82
Health Care
What the data says
MADRIGAL PHARMACEUTICALS, INC.'s debt per share of $15.45 is higher than 78% of companies in the Health Care sector (FY2025). Increased from $6.38 to $15.45 over the past 2 years.
Based on SEC 10-K filings.
15.45 in FY2025 with a 3-year CAGR of +75.1%. Top quartile in the Health Care sector.
Increased from $6.38 to $15.45 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +75.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 82This company $15.45 Sector average $151.59
▼
-89.8% below sector average
Key checks
Key Insights
- In FY2025, debt per share increased 161.1% year-over-year.
- Ranks #18 out of 82 companies in the Health Care sector.
- Lowest debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.45 | +161.1% |
| FY2024 | $5.92 | -7.3% |
| FY2023 | $6.38 | +121.8% |
| FY2022 | $2.88 | - |
| FY2021 | $0.00 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026